IDO1 and cancer: In addition, patients with advanced lung cancer had significantly higher IDO activity and lower TRP concentrations than those in the early stages (p = 0.005 and p = 0.021 respectively) suggesting that TRP degradation may occur more significantly with advanced stage cancer [28].